Nasdaq: BIIBStockForm 13F30 Jun 2026

Hedge funds that hold Biogen Inc. Nasdaq: BIIB

CUSIP 09062X103 · who reports it, how much, and how much it matters to them

35 of the 720 hedge fund managers we track reported shares of Biogen Inc. (Nasdaq: BIIB) on Form 13F for 30 June 2026. Between them they reported USD 471m. The largest position belongs to Citadel Advisors, at USD 90m. The manager with the most riding on it is Palo Alto Investors, where it is 4.2% of the reported book.

Managers reporting it35of 720 we track
Value they reportUSD 471mshares only, 30 Jun 2026
Funds they run632with a file on PPLI.com
Largest positionUSD 90mCitadel Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight4.2%Palo Alto Investors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

35 managers, USD 471m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Biogen Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Citadel Advisors32 funds on PPLI.comUSD 90m0.0%
2Perceptive Advisors6 funds on PPLI.comUSD 60m0.9%
3Balyasny Asset Management25 funds on PPLI.comUSD 57m0.1%
4Palo Alto Investors6 funds on PPLI.comUSD 30m4.2%
5Adage Capital Management1 fund on PPLI.comUSD 28m0.0%
6Sphera Funds Management1 fund on PPLI.comUSD 21m2.7%
7Hudson Bay Capital Management8 funds on PPLI.comUSD 19m0.1%
8POINT72 Asset Management17 funds on PPLI.comUSD 19m0.0%
9Freestone Grove Partners1 fund on PPLI.comUSD 18m0.1%
10Renaissance Technologies13 funds on PPLI.comUSD 17m0.0%
11D. E. Shaw & Co.15 funds on PPLI.comUSD 16m0.0%
12Cinctive Capital Management5 funds on PPLI.comUSD 16m0.6%
13Farallon Capital Management56 funds on PPLI.comUSD 15m0.1%
14Orbimed Advisors1 fund on PPLI.comUSD 13m0.2%
15Polymer Capital Management (HK)1 fund on PPLI.comUSD 8.4m0.4%
16IFM Investors Pty7 funds on PPLI.comUSD 7.8m0.1%
17CIBC Asset Management69 funds on PPLI.comUSD 7.6m0.0%
18Verition Fund Management3 funds on PPLI.comUSD 6.7m0.0%
19Artia Global Partners1 fund on PPLI.comUSD 4m0.7%
20Kinneret Advisory7 funds on PPLI.comUSD 3.9m0.3%
21Marshall Wace LLP84 funds on PPLI.comUSD 2.7m0.0%
22Lighthouse Investment Partners190 funds on PPLI.comUSD 1.6m0.0%
23Two Sigma Investments35 funds on PPLI.comUSD 1.5m0.0%
24Squarepoint Ops7 funds on PPLI.comUSD 1.5m0.0%
25LMR Partners2 funds on PPLI.comUSD 1.1m0.0%
26Holocene Advisors2 funds on PPLI.comUSD 1m0.0%
27Trust Asset Management4 funds on PPLI.comUSD 769,0000.0%
28Exoduspoint Capital Management7 funds on PPLI.comUSD 620,0000.0%
299823 Capital2 funds on PPLI.comUSD 539,0000.4%
30Entrypoint Capital1 fund on PPLI.comUSD 371,0000.1%
31Fulcrum Asset Management LLP7 funds on PPLI.comUSD 335,0000.0%
32Sarissa Capital Management6 funds on PPLI.comUSD 205,0000.1%
33Bayforest Capital1 fund on PPLI.comUSD 144,0000.1%
34Walleye Capital8 funds on PPLI.comUSD 123,0000.0%
35The Quarry1 fund on PPLI.comUSD 1,5120.0%
Next: where it matters most
Where it matters most

For Palo Alto Investors it is 4.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Palo Alto InvestorsUSD 30m4.2%
2Sphera Funds ManagementUSD 21m2.7%
3Perceptive AdvisorsUSD 60m0.9%
4Artia Global PartnersUSD 4m0.7%
5Cinctive Capital ManagementUSD 16m0.6%
6Polymer Capital Management (HK)USD 8.4m0.4%
79823 CapitalUSD 539,0000.4%
8Kinneret AdvisoryUSD 3.9m0.3%
9Orbimed AdvisorsUSD 13m0.2%
10Bayforest CapitalUSD 144,0000.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Biogen Inc.

What is the ticker symbol of Biogen Inc.?

Biogen Inc. trades under the symbol BIIB on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09062X103.

Which hedge funds own Biogen Inc. (Nasdaq: BIIB)?

35 of the 720 hedge fund managers PPLI.com tracks reported Biogen Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 90m), Perceptive Advisors (USD 60m), Balyasny Asset Management (USD 57m), Palo Alto Investors (USD 30m) and Adage Capital Management (USD 28m).

How many hedge funds hold Biogen Inc.?

35 managers in our coverage reported it, and between them they run 632 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Biogen Inc.?

Palo Alto Investors, where the position was 4.2% of the reported 13F book at 30 June 2026.

Does this show who is short Biogen Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Biogen Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.